Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06566300

Autologous Nanofat Grafting by Injection Versus With Microneedling in Post-burn and Traumatic Atrophic Scars

This study aims to evaluate the efficiency autologous nanofat injection versus autologous nanofat delivered by microneedling in management of post burn atrophic and traumatic scars.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Scars Cicatrix Fibrosis Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 1. Males and females between 18-60 years old. 2. Post-burn or traumatic atrophic scar > 6 months duration (16). 3. Patients not receiving any treatments for the scar within the past 3 months.

Exclusion criteria

  • 1. Patients with contractures, hypertrophic and keloid scars. 2. Patients with history of bleeding disorders or coagulopathy, or on anticoagulant therpy.
  • Diabetes and other systemic diseases that may be complicated by the procedure.
  • Pregnant and lactating females. 5. BMI less than 18.5 6. Patients with scars at the donor site

Treatment and study plan

injection of autologous nanofat grafting

Procedure

Injection of nanfat graft

microneedling with autologus nanofat graft

Procedure

delivery of nanofat graft with microneedling

Primary outcomes

  1. change in the scar by by the patient and observer scar assessment scale (POSAS).

    Time frame: 6 months after the proceedure

    patient and observer scar assessment scale score will be uesd

Study contacts

Contact information is provided by the study sponsor or research team.

Dalia I Halwag, PhD, MD

CONTACT

[email protected]

0201224489473

Sponsors and collaborators

Lead sponsor

Alexandria University

Other

Registry information

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Aug 22, 2024
Registry last updated
Nov 5, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.